Willkie has extensive experience in the health care and life sciences field, both in the United States and abroad. We represent companies and investors in the areas of biotechnology, pharmaceuticals, medical technology, wellness and providers. Our work includes corporate transactions, mergers and acquisitions, joint venture transactions, compliance matters, IP issues, patent litigation and counseling, and general litigation.

Related Practice Areas


  • Ad hoc group of first lien lenders, including Silver Point Finance, LLC and Capital Research & Management Company, in Rotech’s ongoing chapter 11 case.

  • Bridge loan commitment and 144A offering of $150 million of senior subordinated notes of Hanger in connection with its acquisition of NovaCare.
  • Platinum Equity in the financing of its $2.1 billion acquisition of LifeScan Diagnostic Systems’ manufacturing business. 
  • Platinum Equity in the financing of its acquisition of Pelican Products, a leading designer and manufacturer of high-performance protective cases and rugged gear, and temperature-controlled supply chain solutions for the healthcare industry. 

  • Transaction involving a $350 million cross-border financing for PerkinElmer, a global provider of advanced technology solutions..
  • Senior executive representation for ReAble, a leading medical device company in the rehabilitation and orthopedics markets.

  • Represented Johnson & Johnson, a multinational manufacturer of healthcare, personal hygiene and pharmaceutical products.
  • A leading manufacturer of medical devices in multiple patent infringement cases.
  • A medical device manufacturer in a lawsuit for trade secret misappropriation and patent infringement. The plaintiff voluntarily dismissed his patent infringement claim with prejudice rather than defend against a motion for summary judgment of patent invalidity. The Sixth Circuit then unanimously affirmed the grant of summary judgment of no trade secret misappropriation. 
  • Represented Philips Medical Systems in enforcing and defending against 21 patents relating to several different facets of automatic external defibrillator (AED) technology.

  • AdaptHealth in the following transactions:
    • its $2 billion acquisition of home medical equipment provider AeroCare. 
    • its business combination with special purpose acquisition company DFB Healthcare Acquisitions Corp. 
    • its equity investments from One Equity Partners and Deerfield Management in connection with AdaptHealth’s acquisitions of Solara Medical Supplies, LLC and ActivStyle, Inc. 
  • Court Square Capital Partners on the sale of Medical Knowledge Group to Novo Holdings. 
  • Court Square Capital Partners in the recapitalization and acquisition of Medical Knowledge Group from WindRose Health Investors.
  • Certain shareholders of cryotherapy company Galil Medical in its sale to BTG plc.
  • GHO Capital on its investment in Sanner Group. 
  • HealthEquity in its acquisition of Luum, a technology platform for employee commute management. 
  • Insight Partners in its significant investment in electronic health record and practice management provider CentralReach. 
  • Insight Partners as lead co-investor in an equity consortium in an agreement to acquire Inovalon for $7.3 billion. 
  • Insightful Science, a portfolio company of Insight Partners, in its acquisition of Dotmatics, a scientific informatics software and services company. 
  • ICG Europe VII, an affiliate of Intermediate Capital Group, in its investment in Biogroup, a leading French operator of medical diagnostic laboratories. 
  • Loyale Healthcare, a leading provider of patient payment and engagement solutions, in its acquisition by RevSpring. 
  • NanoString Technologies, Inc. in the bankruptcy court-supervised sale of its assets to Bruker Corporation for approximately $392.6 million and in the initial stalkinghorse asset purchase agreement with Patient Square Capital.
  • PAI Partners and its portfolio company Amplitude Surgical on the sale of Amplitude’s subsidiary Novastep to Enovis Corporation.
  • PAI Partners in connection with its contemplated acquisition of a majority stake in Euronext listed Amplitude Surgical, a French leader on the global surgical technology market for lower-limb orthopedics. 
  • Qualium Investissement on its announced sale of its majority stake in IMV Technologies to Montagu Private Equity.
  • Sebia on the acquisition of specialty diagnostic leader ORGENTEC Diagnostika from Water Street Healthcare Partners. 
  • Solmetex, LLC, a portfolio company of Avista Capital Partners, on its acquisition of Impladent Ltd. 
  • The Capstreet Group in the completion of its majority recapitalization of Surgical Notes LLC, a group of Texas-based companies that provide healthcare coding and billing services.
  • Virgin Pulse in its sale to Marlin Equity Partners. 
  • Voalte, a pioneer and leader in real-time, mobile healthcare communications, in its sale to global medical technology company Hill-Rom for $180 million.
  • Warburg and Credit Suisse First Boston in connection with investments in this leading global provider.
  • WebPT, a portfolio company of Warburg Pincus, in its acquisition of Clinicient.